苏州近岸蛋白质科技股份有限公司关于部分募集资金专户注销的公告

Core Points - The company has completed the cancellation of certain fundraising special accounts as part of its fundraising management process [1][3] - The total amount raised from the initial public offering (IPO) was RMB 186,298.25 million, with a net amount of RMB 174,219.58 million after deducting issuance costs [1] - The company has established a fundraising management system to ensure the proper use and supervision of the raised funds [2] Fundraising Account Management - The company opened special accounts for fundraising in accordance with relevant laws and regulations to enhance fund management and protect investor rights [2] - A tripartite supervision agreement was signed with the commercial bank and the sponsor to ensure compliance with the management of the fundraising accounts [2] Cancellation of Fundraising Accounts - The company held board and supervisory meetings to approve the change of the implementation location for the "R&D Center Construction Project" and subsequently canceled the fundraising special account for its subsidiary [3] - The funds allocated for the "R&D Center Construction Project" will be transferred to a new special account under the new implementation entity [3]